Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancer.
Krug LM; Miller VA; Kalemkerian GP; Kraut MJ; Ng KK; Heelan RT; Pizzo BA; Perez W; McClean N; Kris MG; Annals Of Oncology: Official Journal Of The European Society For Medical Oncology / ESMO, 2000, vol. 11, issue 2, p 227, ISSN 09237534. ISBN 09237534.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef